Saturday, November 23, 2024
HomeHealthMenopause care platform Gennev becomes Aetna in-network provider

Menopause care platform Gennev becomes Aetna in-network provider

Gennev, a digital menopause care delivery platform, announced it is now an in-network provider for most of Aetna’s commercial health plans nationwide. 

Seattle-based Gennev, previously known as Genneve, provides menopause patients with personalized treatment through its network of OB-GYNs, health coaches and registered dietitians.

Gennev will be available to most of Aetna’s commercial members without prior authorization, while HMO members may require a referral. 

“Gennev providers help women understand where they are in their 7–10-year journey, then they deliver a customized, evidence-based plan to help them feel relief. This agreement with Aetna will increase access to this menopause care for millions of American women, while helping to reinforce the need for this care with both employers and the women struggling to find solutions,” Jill Angelo, CEO of Gennev, said in a statement. 

THE LARGER TREND

In October, Unified Women’s Healthcare, a Florida-based health-management company focused solely on women, acquired Gennev for an undisclosed amount.

Last week, the menopause care provider announced a partnership with hybrid outpatient mental healthcare provider LifeStance Health to provide Gennev’s patients with referrals to LifeStance’s psychiatric and psychotherapy clinicians tailored to the needs of women with menopause. 

Another menopause-focused company is telehealth startup Evernow, which matches users to a clinician who helps build a personalized treatment plan based on the patient’s health history. 

Northwell Holdings and Aegis Ventures also reside in the space. The companies launched the virtual menopause care company Upliv in November, the first company formed through their partnership focused on equity in women’s healthcare.



This story originally appeared on MobiHealthNews

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments